Abstract
Recent studies have shown that psoriasis is associated with an increased prevalence of erectile dysfunction. To our knowledge, no comparative study has considered simultaneously the role of organic factors and psychological factors in this process. We performed a prospective case series study matched by age to explore the prevalence of erectile dysfunction in psoriasis patients compared to a healthy population and to investigate the role of anxiety, depression, and cardiovascular risk factors in the relationship between psoriasis and erectile dysfunction. The healthy group was matched by frequency to cases by age. Seventy-nine patients with moderate to severe psoriasis and 79 healthy controls participated in the study. Participants completed the Massachusetts General Hospital Sexual Functioning Questionnaire and the Hospital Anxiety and Depression Scale. Psoriasis patients had an increased prevalence of erectile dysfunction in comparison to controls, 34.2 vs. 17.7 % (p < .05). Multivariate analysis showed a significant association between erectile dysfunction and age, smoking and anxiety/depression, but not with psoriasis per se. In conclusion, the higher prevalence of smoking and anxiety/depression among patients with moderate to severe psoriasis probably explains the higher prevalence of erectile dysfunction in this population.
Similar content being viewed by others
References
Ahdout, J., Kotlerman, J., Elashoff, D., Kim, J., & Chiu, M. W. (2012). Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis. Clinical and Experimental Dermatology, 37, 477–483. doi:10.1111/j.1365-2230.2012.04360.x.
AlShahwan, M. A. (2015). The prevalence of anxiety and depression in arab dermatology patients. Journal of Cutaneous Medicine and Surgery, 19, 297–303. doi:10.2310/7750.2014.14110.
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013). Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. Journal of the American Academy of Dermatology, 68, 654–662. doi:10.1016/j.jaad.2012.08.015.
Cabete, J., Torres, T., Vilarinho, T., & Ferreira, A. (2014). Erectile dysfunction in psoriasis patients. European Journal of Dermatology, 24, 482–486. doi:10.1684/ejd.2014.2388.
Chen, Y. J., Chen, C. C., Lin, M. W., Chen, T. J., Li, C. Y., Hwang, C. Y., … Liu, H. N. (2013). Increased risk of sexual dysfunction in male patients with psoriasis: A nationwide population-based follow-up study. Journal of Sexual Medicine, 10, 1212–1218. doi:10.1111/j.1743-6109.2012.02767.x.
Chew, K. K. (2004). Prevalence of erectile dysfunction in community-based studies. International Journal of Impotence Research, 16, 201–202. doi:10.1038/sj.ijir.3901181.
Chung, S. D., Keller, J. J., Chu, T. W., & Lin, H. C. (2012). Psoriasis and the risk of erectile dysfunction: A population-based case-control study. Journal of Sexual Medicine, 9, 130–135. doi:10.1111/j.1743-6109.2011.02510.x.
Corona, G., Mannucci, E., Forti, G., & Maggi, M. (2009). Hypogonadism, ED, metabolic syndrome and obesity: A pathological link supporting cardiovascular diseases. International Journal of Andrology, 32, 587–598. doi:10.1111/j.1365-2605.2008.00951.x.
Corona, G., Ricca, V., Bandini, E., Rastrelli, G., Casale, H., Jannini, E. A., & Maggi, M. (2012). SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. Journal of Sexual Medicine, 9, 2017–2026. doi:10.1111/j.1743-6109.2012.02762.x.
Derogatis, L. R. (2008). Clinical and research evaluations of sexual dysfunctions. Advances in Psychosomatic Medicine, 29, 7–22. doi:10.1159/000126621.
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151, 54–61. doi:10.1038/sj.ijir.3901181.
Ghazi, L. J., Patil, S. A., & Cross, R. K. (2015). Sexual dysfunction in inflammatory bowel disease. Inflammatory Bowel Diseases, 21, 939–947. doi:10.1097/mib.0000000000000260.
Goulding, J. M., Price, C. L., Defty, C. L., Hulangamuwa, C. S., Bader, E., & Ahmed, I. (2011). Erectile dysfunction in patients with psoriasis: Increased prevalence, an unmet need, and a chance to intervene. British Journal of Dermatology, 164, 103–109. doi:10.1111/j.1365-2133.2010.10077.x.
Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., & Wespes, E. (2010). Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. European Journal of Urology, 57, 804–814. doi:10.1016/j.eururo.2010.02.020.
Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Salonia, A., … Wespes, E. (2013). Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Retrieved from http://uroweb.org/wp-content/uploads/12-Male-Sexual-Dysfunction_LR-.pdf.
Hayes, J., & Koo, J. (2010). Psoriasis: Depression, anxiety, smoking, and drinking habits. Dermatology Therapy, 23, 174–180. doi:10.1111/j.1529-8019.2010.01312.x.
Holt, R. I., Phillips, D. I., Jameson, K. A., Cooper, C., Dennison, E. M., & Peveler, R. C. (2013). The relationship between depression, anxiety and cardiovascular disease: Findings from the Hertfordshire Cohort Study. Journal of Affective Disorders, 150, 84–90. doi:10.1016/j.jad.2013.02.026.
Kubin, M., Wagner, G., & Fugl-Meyer, A. R. (2003). Epidemiology of erectile dysfunction. International Journal of Impotence Research, 15, 63–71. doi:10.1038/sj.ijir.3900949.
Kurd, S. K., Troxel, A. B., Crits-Christoph, P., & Gelfand, J. M. (2010). The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study. Archives of Dermatology, 146, 891–895. doi:10.1001/archdermatol.2010.186.
Labbate, L. A., & Lare, S. B. (2001). Sexual dysfunction in male psychiatric outpatients: Validity of the Massachusetts General Hospital Sexual Functioning Questionnaire. Psychotherapy and Psychosomatics, 70, 221–225. doi:10.1159/000056257.
Litwin, M. S., Nied, R. J., & Dhanani, N. (1998). Health-related quality of life in men with erectile dysfunction. Journal of General Internal Medicine, 13, 159–166. doi:10.1046/j.1525-1497.1998.00050.x.
Martin-Morales, A., Sanchez-Cruz, J. J., Saenz de Tejada, I., Rodriguez-Vela, L., Jimenez-Cruz, J. F., & Burgos-Rodriguez, R. (2001). Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina Study. Journal of Urology, 166, 569–574. doi:10.1016/S0022-5347)05=65986-1.
McDermott, E., Mullen, G., Moloney, J., Keegan, D., Byrne, K., Doherty, G. A., & Mulcahy, H. E. (2015). Body image dissatisfaction: Clinical features, and psychosocial disability in inflammatory bowel disease. Inflammatory Bowel Diseases, 21, 353–360. doi:10.1097/mib.0000000000000287.
McDonough, E., Ayearst, R., Eder, L., Chandran, V., Rosen, C. F., Thavaneswaran, A., & Gladman, D. D. (2014). Depression and anxiety in psoriatic disease: Prevalence and associated factors. Journal of Rheumatology, 41, 887–896. doi:10.3899/jrheum.130797.
McMahon, C. G. (2014). Erectile dysfunction. Internal Medicine Journal, 44, 18–26. doi:10.1111/imj.12325.
Miettinen, O. S., & Cook, E. F. (1981). Confounding: Essence and detection. American Journal of Epidemiology, 114, 593–603.
Morse, W. I., & Morse, J. M. (1982). Erectile impotence precipitated by organic factors and perpetuated by performance anxiety. Canadian Medical Association Journal, 127, 599–601.
Naccarato, A. M., Reis, L. O., Zani, E. L., Cartapatti, M., & Denardi, F. (2014). Psychotherapy: A missing piece in the puzzle of post radical prostatectomy erectile dysfunction rehabilitation. Actas Urologicas Españolas, 38, 385–390. doi:10.1016/j.acuro.2013.10.012.
Navines, R., Castellvi, P., Moreno-Espana, J., Gimenez, D., Udina, M., Canizares, S., … Martin-Santos, R. (2012). Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health Questionnaire. Journal of Affective Disorders, 138, 343–351. doi:10.1016/j.jad.2012.01.018.
Nehra, A., Jackson, G., Miner, M., Billups, K. L., Burnett, A. L., Buvat, J., … Wu, F. C. (2012). The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clinic Proceedings, 87, 766–778. doi:10.1016/j.mayocp.2012.06.015.
Nelson, C. J., Mulhall, J. P., & Roth, A. J. (2011). The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer. Journal of Sexual Medicine, 8, 560–566. doi:10.1111/j.1743-6109.2010.02127.x.
Nunes, K. P., Labazi, H., & Webb, R. C. (2012). New insights into hypertension-associated erectile dysfunction. Current Opinion in Nephrology Hypertension, 21, 163–170. doi:10.1097/MNH.0b013e32835021bd.
Puig, L., Bordas, X., Carrascosa, J. M., Dauden, E., Ferrandiz, C., Hernanz, J. M., … Vazquez-Veiga, H. (2009). Documento de consenso sobre la evaluacion y el tratamiento de la psoriasis moderada/grave del grupo espanol de psoriasis de la Academia Espanola de Dermatologia y Venereologia [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology]. Actas Dermosifiliograficas, 100, 277–286.
Quintana, J. M., Padierna, A., Esteban, C., Arostegui, I., Bilbao, A., & Ruiz, I. (2003). Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinava, 107, 216–221. doi:10.1034/j.1600-0447.2003.00062.x.
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., Jr., & Reboussin, D. M. (1999). Psoriasis causes as much disability as other major medical diseases. Journal of the American Academy of Dermatology, 41, 401–407. doi:10.1016/S0190-9622(99)70112-X.
Raychaudhuri, S. P., & Farber, E. M. (2001). The prevalence of psoriasis in the world. Journal of the European Academy of Dermatology and Venereology, 15, 16–17. doi:10.1046/j.1468-3083.2001.00192.x.
Rieder, E., & Tausk, F. (2012). Psoriasis, a model of dermatologic psychosomatic disease: Psychiatric implications and treatments. International Journal of Dermatology, 51, 12–26. doi:10.1111/j.1365-4632.2011.05071.x.
Robinson, A., Kardos, M., & Kimball, A. B. (2012). Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 66, 369–375. doi:10.1016/j.jaad.2011.01.022.
Rosen, R. C., Seidman, S. N., Menza, M. A., Shabsigh, R., Roose, S. P., Tseng, L. J., … Siegel, R. L. (2004). Quality of life, mood, and sexual function: A path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms. International Journal of Impotence Research, 16, 334–340. doi:10.1038/sj.ijir.3901197.
Russo, P. A., Ilchef, R., & Cooper, A. J. (2004). Psychiatric morbidity in psoriasis: A review. Australasian Journal of Dermatology, 45, 155–159; quiz 160–151. doi:10.1111/j.1440-0960.2004.00078.x.
Schmidt, H. M., Munder, T., Gerger, H., Fruhauf, S., & Barth, J. (2014). Combination of psychological intervention and phosphodiesterase-5 inhibitors for erectile dysfunction: A narrative review and meta-analysis. Journal of Sexual Medicine, 11, 1376–1391. doi:10.1111/jsm.12520.
Sierra, J. C., Vallejo-Medina, P., Santos-Iglesias, P., & Lameiras Fernandez, M. (2012). Validation of Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) in a Spanish population. Atencion Primaria, 44, 516–524. doi:10.1016/j.aprim.2012.02.004.
Tasliyurt, T., Bilir, Y., Sahin, S., Seckin, H. Y., Kaya, S. U., Sivgin, H., … Erdemir, F. (2014). Erectile dysfunction in patients with psoriasis: Potential impact of the metabolic syndrome. European Review for Medical and Pharmacological Sciences, 18, 581–586.
Tostes, R. C., Carneiro, F. S., Lee, A. J., Giachini, F. R., Leite, R., Osawa, Y., & Webb, R. C. (2008). Cigarette smoking and erectile dysfunction: Focus on NO bioavailability and ROS generation. Journal of Sexual Medicine, 5, 1284–1295. doi:10.1111/j.1743-6109.2008.00804.x.
Tristano, A. G. (2014). Impact of rheumatoid arthritis on sexual function. World Journal of Orthopedics, 5, 107–111. doi:10.5312/wjo.v5.i2.107.
Turel Ermertcan, A., Temeltas, G., Deveci, A., Dinc, G., Guler, H. B., & Ozturkcan, S. (2006). Sexual dysfunction in patients with psoriasis. Journal of Dermatology, 33, 772–778. doi:10.1111/j.1346-8138.2006.00179.x.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinava, 67, 361–370. doi:10.1111/j.1600-0447.1983.tb09716.x.
Acknowledgments
The authors thank Jean Sanders and Ingrid de Ruiter for improving the use of English in the article. The results of this study are part of Ph.D. work of Alejandro Molina-Leyva.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Molina-Leyva, A., Molina-Leyva, I., Almodovar-Real, A. et al. Prevalence and Associated Factors of Erectile Dysfunction in Patients With Moderate to Severe Psoriasis and Healthy Population: A Comparative Study Considering Physical and Psychological Factors. Arch Sex Behav 45, 2047–2055 (2016). https://doi.org/10.1007/s10508-016-0757-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-016-0757-8